Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04110288 · ClinicalTrials.gov registry record
VQI DELTA Paclitaxel Device Safety Analysis
A clinical trial, sponsored by Lahey Clinic.
- Completed
- Registry status
- 219,483
- Enrollment target
NCT04110288 is a clinical trial that has completed, run by Lahey Clinic. The registered enrollment target is 219,483 participants.
The verdict
NCT04110288 has completed, sponsored by Lahey Clinic.
- COMPLETED
- Registry status
- 219,483 participants
- Enrollment target
Study Summary
The VQI-DELTA Paclitaxel Device Safety Analysis seeks to assess the comparative safety of paclitaxel coated balloons and stents in the treatment of peripheral artery disease (PAD) through analysis of the VQI Peripheral Vascular Intervention (PVI) registry module using the DELTA system.
Interventions
- DRUG Paclitaxel
- DEVICE Non-drug coated Device Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219,483 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2020-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04110288
The ClinicalTrials.gov registry entry for NCT04110288 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 219,483 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paclitaxel is the first listed.
NCT04110288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04110288 about?
NCT04110288 is a clinical study titled "VQI DELTA Paclitaxel Device Safety Analysis". The VQI-DELTA Paclitaxel Device Safety Analysis seeks to assess the comparative safety of paclitaxel coated balloons and stents in the treatment of peripheral artery disease (PAD) through analysis of the VQI Peripheral Vascular Intervention (PVI) registry module using the DELTA system.
What is the current status of trial NCT04110288?
This trial is currently completed. The enrollment target is 219,483 participants. The study started on 2017-01-01. Estimated completion is 2020-04-01.
What interventions are being tested in trial NCT04110288?
The interventions under investigation include: Paclitaxel (DRUG), Non-drug coated Device Treatment (DEVICE).
Who is sponsoring clinical trial NCT04110288?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.